The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
Open accessAbstract
Sickle cell disease (SCD) is a monogenetic disorder due to a single base-pair point mutation in the β-globin gene resulting in the substitution of the amino acid valine for glutamic acid in the β-globin chain. Phenotypic variation in the clinical presentation and disease outcome is a characteristic feature of the disorder. Understanding the pathogenesis and pathophysiology of the disorder is central to the choice of therapeutic development and intervention. In this special edition for newborn screening for haemoglobin disorders, it is pertinent to describe the genetic, pathologic and clinical presentation of sickle cell disease as a prelude to the justification for screening. Through a systematic review of the literature using search terms relating to SCD up till 2019, we identified relevant descriptive publications for inclusion. The scope of this review is mainly an overview of the clinical features of pain, the cardinal symptom in SCD, which present following the drop in foetal haemoglobin as young as five to six months after birth. The relative impact of haemolysis and small-vessel occlusive pathology remains controversial, a combination of features probably contribute to the different pathologies. We also provide an overview of emerging therapies in SCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Piel, F. B., Steinberg, M. H., & Rees, D. C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510865 · Cited by 1,488
Piel, F. B., Patil, A. P., Howes, R. E., Nyangiri, O. A., Gething, P. W., Dewi, M., Temperley, W. H., Williams, T. N., Weatherall, D. J., & Hay, S. I. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61229-x · Cited by 1,196 · cited 1×
“It is estimated that over 80% of over 300,000 annual births occur in sub-Saharan Africa (SSA), the largest burden from Nigeria and Democratic Republic of Congo [13].”
BackgroundSteinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Crizanlizumab for the prevention of pain crises in sickle cell disease.
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T. H., Knight-Madden, J., Alvarez, O. A., Gordeuk, V. R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611770 · Cited by 914
Improved survival of children and adolescents with sickle cell disease
Quinn, C. T., Rogers, Z. R., McCavit, T. L., & Buchanan, G. R. (2010) · Blood · doi:10.1182/blood-2009-07-233700 · Cited by 907
The inherited diseases of hemoglobin are an emerging global health burden
Weatherall, D. J. (2010) · Blood · doi:10.1182/blood-2010-01-251348 · Cited by 903
Grosse, S. D., Odame, I., Atrash, H. K., Amendah, D. D., Piel, F. B., & Williams, T. N. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.09.013 · Cited by 707
Gene therapy in a patient with sickle cell disease
Ribeil, J.-A., Hacein-Bey-Abina, S., Payen, E., Magnani, A., Semeraro, M., Magrin, E., Caccavelli, L., Neven, B., Bourget, P., El Nemer, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609677 · Cited by 696 · cited 1×
“At the time of this writing, a handful of people have apparently been cured of SCD in three gene therapy clinical studies with different lentiviral vectors [89].”
BackgroundPeculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910.
Jb, H. (2001) · PubMed Central · Cited by 676
Piel, F. B., Steinberg, M., & Rees, D. C. (2016) · Spiral (Imperial College London) · doi:10.1056/nejmc1706325#sa6 · Cited by 659
A Phase 3 Trial of l -Glutamine in Sickle Cell Disease
Niihara, Y., Miller, S. T., Kanter, J., Lanzkron, S., Smith, W. R., Hsu, L. L., Gordeuk, V. R., Viswanathan, K., Sarnaik, S., Osunkwo, I., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715971 · Cited by 563
Self-citationFetal hemoglobin in sickle cell anemia
Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H. K., & Steinberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-03-325258 · Cited by 553
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Manwani, D., & Frenette, P. S. (2013) · Blood · doi:10.1182/blood-2013-05-498311 · Cited by 428
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
Sickle cell disease: old discoveries, new concepts, and future promise
Frenette, P. S., & Atweh, G. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30920 · Cited by 400
Telfer, P., Coen, P., Chakravorty, S., Wilkey, O., Evans, J., Newell, H., Smalling, B., Amos, R., Stephens, A., Rogers, D., et al. (2007) · Haematologica · doi:10.3324/haematol.10937 · Cited by 357
Infection in sickle cell disease: A review
Booth, C., Inusa, B., & Obaro, S. K. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.03.010 · Cited by 357
Self-citationMortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania
Makani, J., Cox, S. E., Soka, D., Komba, A. N., Oruo, J., Mwamtemi, H., Magesa, P., Rwezaula, S., Meda, E., Mgaya, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014699 · Cited by 326
The spleen and sickle cell disease: the sick(led) spleen
Brousse, V., Buffet, P., & Rees, D. (2014) · British Journal of Haematology · doi:10.1111/bjh.12950 · Cited by 294
Oteng-Ntim, E., Meeks, D., Seed, P. T., Webster, L., Howard, J., Doyle, P., & Chappell, L. C. (2015) · Blood · doi:10.1182/blood-2014-11-607317 · Cited by 271
Sickle cell disease: a neglected chronic disease of increasing global health importance
Chakravorty, S., & Williams, T. N. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-303773 · Cited by 236
Hydroxyurea for Sickle Cell Disease: A Systematic Review for Efficacy and Toxicity in Children
Strouse, J. J., Lanzkron, S., Beach, M. C., Haywood, C., Park, H., Witkop, C., Wilson, R. F., Bass, E. B., & Segal, J. B. (2008) · Pediatrics · doi:10.1542/peds.2008-0441 · Cited by 217
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin
Metcalf, B., Chuang, C., Dufu, K., Patel, M. P., Silva-Garcia, A., Johnson, C., Lu, Q., Partridge, J. R., Patskovska, L., Patskovsky, Y., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00491 · Cited by 203
Genetic Etiologies for Phenotypic Diversity in Sickle Cell Anemia
Steinberg, M. H. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.10 · Cited by 203
Ballas, S. K., Kesen, M. R., Goldberg, M. F., Lutty, G. A., Dampier, C., Osunkwo, I., Wang, W. C., Hoppe, C., Hagar, W., Darbari, D. S., et al. (2012) · The Scientific World Journal · doi:10.1100/2012/949535 · Cited by 195
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease
Hoban, M. D., Orkin, S. H., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2015-09-618587 · Cited by 194
Dampier, C., LeBeau, P. K., Rhee, S., Lieff, S., Kesler, K. L., Ballas, S. K., Rogers, Z. R., & Wang, W. C. (2010) · American Journal of Hematology · doi:10.1002/ajh.21905 · Cited by 178
Comprehensive care in sickle cell disease: its impact on morbidity and mortality.
Vichinsky, E. P. (1991) · PubMed · Cited by 161
A network model to predict the risk of death in sickle cell disease
Sebastiani, P., Nolan, V. G., Baldwin, C. T., Abad-Grau, M. M., Wang, L., Adewoye, A. H., McMahon, L. C., Farrer, L. A., Taylor, J. G., Kato, G. J., et al. (2007) · Blood · doi:10.1182/blood-2007-04-084921 · Cited by 161
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events
Heeney, M. M., Hoppe, C. C., Abboud, M. R., Inusa, B. P. D., Kanter, J., Ogutu, B. R., Brown, P. B., Heath, L. E., Jakubowski, J. A., Zhou, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512021 · Cited by 161
Self-citationThe challenge of haemoglobinopathies in resource‐poor countries
Weatherall, D. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08742.x · Cited by 158
Lobitz, S., Telfer, P. T., Cela, E., Allaf, B., Angastiniotis, M., Johansson, C. B., Badens, C., Bento, C., Bouva, M. J., Canatan, D., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15600 · Cited by 156
Self-citationMinireview: Genetic basis of heterogeneity and severity in sickle cell disease
Habara, A. H., & Steinberg, M. H. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216636726 · Cited by 152
Sickle Cell Disease: Advances in Treatment
Gardner, R. V. (2018) · Ochsner Journal · doi:10.31486/toj.18.0076 · Cited by 144
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease
Telen, M. J. (2016) · Blood · doi:10.1182/blood-2015-09-618553 · Cited by 140
Psychological therapies for sickle cell disease and pain
Anie, K. A., & Green, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001916.pub3 · Cited by 137
Self-citationIschemia-reperfusion Injury in Sickle Cell Anemia
Hebbel, R. P. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.005 · Cited by 130
Daak, A. A., Ghebremeskel, K., Hassan, Z., Attallah, B., Azan, H. H., Elbashir, M. I., & Crawford, M. A. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.036319 · Cited by 122
Tomer, A., Kasey, S., Connor, W., Clark, S., Harker, L. A., & Eckman, J. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615948 · Cited by 118
Lebensburger, J. D., Miller, S. T., Howard, T. H., Casella, J. F., Brown, C., Lü, M., Iyer, R. V., Sarnaik, S. A., Rogers, Z. R., Wang, W. C., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24037 · Cited by 113
Qureshi, A., Kaya, B., Pancham, S., Keenan, R., Anderson, J., Akanni, M., Howard, J., & the British Society for Haematology (2018) · British Journal of Haematology · doi:10.1111/bjh.15235 · Cited by 104
Haemoglobinopathies in Europe: health & migration policy perspectives
Martinez, P. A., Angastiniotis, M., Eleftheriou, A., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-97 · Cited by 103
Bhatnagar, P., Purvis, S. H., Barron‐Casella, E. A., DeBaun, M. R., Casella, J. F., Arking, D. E., & Keefer, J. R. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.12 · Cited by 100
Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape
Kassim, A. A., & Sharma, D. (2017) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2017.05.008 · Cited by 92
l-Glutamine for sickle cell anemia: more questions than answers
Quinn, C. T. (2018) · Blood · doi:10.1182/blood-2018-03-834440 · Cited by 92
Bonds, D. R. (2004) · Blood Reviews · doi:10.1016/j.blre.2004.04.002 · Cited by 87
Community Health Workers as Support for Sickle Cell Care
Hsu, L. L.-Y., Green, N., Ivy, E. D., Neunert, C. E., Smaldone, A. M., Johnson, S., Castillo, S. R., Castillo, A., Thompson, T., Hampton, K. C., et al. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.01.016 · Cited by 84
Self-citationAudit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years
Modell, B., Petrou, M., Layton, M., Slater, C., Ward, R. H. T., Rodeck, C. H., Varnavides, L., Nicolaides, K. H., Gibbons, S., Fitches, A. C., et al. (1997) · BMJ · doi:10.1136/bmj.315.7111.779 · Cited by 81
Kuznik, A., Habib, A. G., Munube, D., & Lamorde, M. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1572-6 · Cited by 75
THE HAND-FOOT SYNDROME IN SICKLE-CELL DISEASE IN YOUNG CHILDREN
Watson, R. J., Burko, H., MEGAS, H., & Robinson, M. G. (1963) · PEDIATRICS · doi:10.1542/peds.31.6.975 · Cited by 73
Optimizing hydroxyurea therapy for sickle cell anemia
Ware, R. E. (2015) · Hematology · doi:10.1182/asheducation-2015.1.436 · Cited by 68
Makani, J., Soka, D., Rwezaula, S. S., Krag, M., Mghamba, J. M., Ramaiya, K. L., Cox, S. E., & Grosse, S. D. (2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12428 · Cited by 65
Sickle Cell Disease: Management options and challenges in developing countries
Ansong, D., Osei‐Akoto, A., Ocloo, D., & Ohene‐Frempong, K. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.062 · Cited by 64
Associations between environmental factors and hospital admissions for sickle cell disease
Piel, F. B., Tewari, S., Brousse, V. A. M., Analitis, A., Font, A., Menzel, S., Chakravorty, S., Thein, S. L., Inusa, B. P. D., Telfer, P. T., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.154245 · Cited by 61
Self-citationNational registry of hemoglobinopathies in Spain (REPHem)
Cela, E., Bellón, J. M., de la Cruz, M., Beléndez, C., Berrueco, R., Ruiz, A., Elorza, I., de Heredia, C. D., Cervera, Á., Vallès, G., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26322 · Cited by 57
Folate supplementation in people with sickle cell disease
Dixit, R., Nettem, S., Madan, S. S., Soe, H. H. K., Abas, A. L., Vance, L. D., & Stover, P. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011130.pub2 · Cited by 56
Psychosocial burden of sickle cell disease on caregivers in a Nigerian setting.
OHAERI, J. U., & Shokunbi, W. A. (2002) · PubMed Central · Cited by 52
Ingram, V. M. (2004) · Genetics · doi:10.1534/genetics.167.1.1 · Cited by 48
A STUDY OF SICKLING OF YOUNG ERYTHROCYTES IN SICKLE CELL ANEMIA
WATSON, J. (1948) · Blood · doi:10.1182/blood.v3.4.465.465 · Cited by 45
Folate supplementation in people with sickle cell disease
Dixit, R., Nettem, S., Madan, S. S., Soe, H. H. K., Abas, A. L., Vance, L. D., & Stover, P. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011130.pub3 · Cited by 44
Wiebking, V., Hütker, S., Schmid, I., Immler, S., Feuchtinger, T. F., & Albert, M. H. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3030-x · Cited by 42
Hashmi, S. K., Srivastava, A., Rasheed, W. K., Adil, S. N., Wu, T., Jagasia, M., Nassar, A., Hwang, W. Y. K., Hamidieh, A. A., Greinix, H., et al. (2017) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2017.05.017 · Cited by 36
Incidence and Predictors of Bacterial infection in Febrile Children with Sickle Cell Disease.
Morrissey, B., Bycroft, T., Almossawi, O., Wilkey, O., & Daniels, J. (2015) · PubMed · doi:10.3109/03630269.2015.1065419 · Cited by 35
Grosse, R., Lukács, Z., Cobos, P. N., Oyen, F., Ehmen, C., Muntau, B., Timmann, C., & Noack, B. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25706 · Cited by 32
Phytomedicines (medicines derived from plants) for sickle cell disease
Oniyangi, O., & Cohall, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004448.pub5 · Cited by 32
The effects of old and recent migration waves in the distribution of HBB*S globin gene haplotypes
Lindenau, J. D., Wagner, S. C., de Castro, S. M., & Hutz, M. H. (2016) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2016-0032 · Cited by 31
Turf wars: exploring splenomegaly in sickle cell disease in malaria‐endemic regions
Tubman, V. N., & Makani, J. (2017) · British Journal of Haematology · doi:10.1111/bjh.14592 · Cited by 30
Colombatti, R., Martella, M., Cattaneo, L., Viola, G., Cappellari, A., Bergamo, C., Azzena, S., Schiavon, S., Baraldi, E., Barba, B. D., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27657 · Cited by 30
Recent advances in improving the management of sickle cell disease
Inati, A. C. (2009) · Blood Reviews · doi:10.1016/s0268-960x(09)70004-9 · Cited by 25
Hypertransfusion Therapy in Sickle Cell Disease in Nigeria
Adewoyin, A. S., & Obieche, J. C. (2014) · Advances in Hematology · doi:10.1155/2014/923593 · Cited by 21
Mulder, N., Nembaware, V., Adekile, A. D., Anie, K. A., Inusa, B. P. D., Brown, B. J., Campbell, A., Chinenere, F., Chunda-Liyoka, C. M., Derebail, V. K., et al. (2016) · Applied & Translational Genomics · doi:10.1016/j.atg.2016.03.005 · Cited by 19
Self-citationHoppe, C. C., Styles, L. A., Heath, L. E., Zhou, C., Jakubowski, J. A., Winters, K. J., Brown, P. B., Rees, D. C., & Heeney, M. M. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25771 · Cited by 17
Inusa, B. P. D., Anie, K. A., Lamont, A. E., Dogara, L. G., Ojo, B., Ijei, I., Atoyebi, W., Gwani, L., Gani, E., & Hsu, L. L.-Y. (2018) · International Journal of Neonatal Screening · doi:10.3390/ijns4040033 · Cited by 17
Self-citationInusa, B. P. D., Atoyebi, W., Hassan, A. A., Idhate, T., Dogara, L. G., Ijei, I., Qin, Y., Anie, K. A., Lawson, J. O., & Hsu, L. L.-Y. (2018) · F1000Research · doi:10.12688/f1000research.14589.1 · Cited by 10
Self-citationSickle cell disease in childhood
Matthews, C. E., Walton, E. K., & Inusa, B. P. D. (2014) · BMJ · doi:10.1136/sbmj.g115 · Cited by 4
Self-citation
Metadata
- Authors
- Inusa, B., Hsu, L., Kohli, N., Patel, A., Ominu-Evbota, K., Anie, K., & Atoyebi, W.
- Venue
- International Journal of Neonatal Screening
- Publisher
- MDPI AG
- Published
- 2019-05-07
- Volume
- 5
- Issue
- 2
- Pages
- 20
- ISSN
- 2409-515X (ISSN-L)
- OpenAlex
- W2944030358
- Cited by
- 313
- References
- 75
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.